All Stories

  1. Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4

    Article • mAbs, June 2019, Taylor & Francis

    Mark Frigerio

  2. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates

    Article • Current Topics in Medicinal Chemistry, February 2018, Bentham Science Publishers

    Mark Frigerio